摘要:
The present invention relates to a compound of Formula (I) and the manufacturing method(s) thereof and the use thereof: wherein: Ar is a nitrogen-containing heteroaromatic ring group; X and Z are each a carbon atom, and so on; Y is CO, and so on; R1 is a hydrogen atom, and so on; R2 and R3 are each a hydrogen atom, and so on; R4 and R5 are each a hydrogen atom, and so on; and the formula is a single bond or a double bond. According to the present invention, the compound of the present invention can provide Cdk4 and/or Cdk6 inhibitors for treating malignant tumors, because the compounds of the present invention exhibit a prominent growth inhibitory activity against tumor cells.
摘要翻译:本发明涉及式(I)化合物及其制备方法及其用途:其中:Ar为含氮杂芳环; X和Z各自为碳原子,等等; Y是CO,等等; R 1是氢原子等等; R 2和R 3各自为氢原子等; R 4和R 5各自为氢原子,等等; 并且公式是单键或双键。 根据本发明,本发明化合物可以提供用于治疗恶性肿瘤的Cdk4和/或Cdk6抑制剂,因为本发明的化合物对肿瘤细胞表现出显着的生长抑制活性。
摘要:
Novel isoquinoline derivatives represented by formula (I): ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, X.sup.1 and X.sup.2 are as defined in the specification, have an anti-arrhythmic activity and bradycardiac activity and are effective for the treatment of arrhythmia, myocardiac infarction or angina pectoris.
摘要:
The present invention relates to a compound of Formula (I) and the manufacturing method(s) thereof and the use thereof: Formula (I) wherein: Ar is a nitrogen-containing heteroaromatic ring group; X and Z are each a carbon atom, and so on; Y is CO, and so on; R1 is a hydrogen atom, and so on; R2 and R3 are each a hydrogen atom, and so on; R4 and R5 are each a hydrogen atom, and so on; and the formula is a single bond or a double bond. According to the present invention, the compound of the present invention can provide Cdk4 and/or Cdk6 inhibitors for treating malignant tumors, because the compounds of the present invention exhibit a prominent growth inhibitory activity against tumor cells.
摘要翻译:本发明涉及式(I)化合物及其制备方法及其用途:式(I)其中:Ar为含氮杂芳环; X和Z各自为碳原子,等等; Y是CO,等等; R 1是氢原子等等; R 2和R 3各自为氢原子等; R 4和R 5各自为氢原子,等等; “img id =”custom-character-00001“he =”3.13mm“wi =”6.01mm“file =”US20070027147A1-20070201-P00001.TIF“alt =”custom character“img-content =”character“ img-format =“tif”/>是单键或双键。 根据本发明,本发明化合物可以提供用于治疗恶性肿瘤的Cdk4和/或Cdk6抑制剂,因为本发明的化合物对肿瘤细胞表现出显着的生长抑制活性。
摘要:
The present invention relates to a compound of the general formula (I): [Ar1 is aryl fused to the adjacent pyrazinone ring at the 5th and 6th positions, etc., X is CO, etc., Y is CH, etc., Z is CH, etc., V is CH, etc., Wn is —(CH2)n— (n is zero to four), R1, is H or optionally substituted lower alkyl, etc., R2 is H, etc., R3 and R4 are the same or different and are each H, etc., R5 and R6 are the same or different and are each H, hydroxy, etc.] or a pharmaceutically acceptable salt or ester thereof; a pharmaceutical composition, an inhibitor of Cdk4 and/or Cdk6 or an anti-cancer agent, containing the same as an active ingredient; and a process for preparing them.
摘要:
The present invention relates to a cyclopentenopyridine derivative represented by general formula (I) or a pharmaceutically acceptable salt thereof, wherein Ar is a phenyl group or the like. R1 is a mono- or di-C1-C6 alkylamino group or the like, and R2 is a hydroxyl group or the like, a process for its production and its use.
摘要:
A plant which belongs to the genus Limonium, having a characteristic of undergoing flower bud differentiation and flower stalk development within 50 days from seeding even without low temperatures of 25° C. or below; and a method for creating the plant are disclosed.
摘要:
The present invention relates to a compound of Formula (I) and the manufacturing method(s) thereof and the use thereof:Formula (I) wherein: Ar is a nitrogen-containing heteroaromatic ring group; X and Z are each a carbon atom, and so on; Y is CO, and so on; R1 is a hydrogen atom, and so on; R2 and R3 are each a hydrogen atom, and so on; R4 and R5 are each a hydrogen atom, and so on; and the formula is a single bond or a double bond. According to the present invention, the compound of the present invention can provide Cdk4 and/or Cdk6 inhibitors for treating malignant tumors, because the compounds of the present invention exhibit a prominent growth inhibitory activity against tumor cells.
摘要翻译:本发明涉及式(I)化合物及其制备方法及其用途:式(I)其中:Ar为含氮杂芳环; X和Z各自为碳原子,等等; Y是CO,等等; R 1是氢原子等等; R 2和R 3各自为氢原子等; R 4和R 5各自为氢原子,等等; “img id =”CUSTOM-CHARACTER-00001“he =”3.13mm“wi =”6.01mm“file =”US07354946-20080408-P00001.TIF“alt =”自定义字符“img-content =”character“ img-format =“tif”/>是单键或双键。 根据本发明,本发明化合物可以提供用于治疗恶性肿瘤的Cdk4和/或Cdk6抑制剂,因为本发明的化合物对肿瘤细胞表现出显着的生长抑制活性。
摘要:
The present invention relates to a compound of the general formula (I): [Ar1 is aryl fused to the adjacent pyrazinone ring at the 5th and 6th positions, etc., X is CO, etc., Y is CH, etc., Z is CH, etc., V is CH, etc., Wn is —(CH2)n— (n is zero to four), R1, is H or optionally substituted lower alkyl, etc., R2 is H, etc., R3 and R4 are the same or different and are each H, etc., R5 and R6 are the same or different and are each H, hydroxy, etc.] or a pharmaceutically acceptable salt or ester thereof; a pharmaceutical composition, an inhibitor of Cdk4 and/or Cdk6 or an anti-cancer agent, containing the same as an active ingredient; and a process for preparing them.
摘要:
A heteroaromatic ring-fused cyclopentene derivative of the formula: ##STR1## wherein the variables are as defined in the specification; or a pharmaceutically acceptable salt thereof.